MKI67 and neoplasm: Further analysis using Ki67 immunohistochemistry (IHC) indicated that both ASO drugs alone and the combination of Elesclomol with CuCl2 effectively inhibited tumor growth, with the most substantial suppressive effect observed in the group treated with ASO drugs combined with copper ionophores (Figure 7e,f).